Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors

about

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine.

P2860

Q55263815-A0031012-B0E2-428A-A624-93DF36B2B055

P2860

Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors

Item

http://www.wikidata.org/entity/Q36012272

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@ast

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@en

type

Item

label

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@ast

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@en

prefLabel

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@ast

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@en

P1476

Circulating Chromogranin A as ...... ncreatic Neuroendocrine Tumors

@en

P2093

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jing Gao

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Ming Lu

http://www.w3.org/2001/XMLSchema#string

Na Li

http://www.w3.org/2001/XMLSchema#string

Tiantian Tian

http://www.w3.org/2001/XMLSchema#string

Yanyan Li

http://www.w3.org/2001/XMLSchema#string

Zhihao Lu

http://www.w3.org/2001/XMLSchema#string

Zhongwu Li

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.

Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.

Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas.

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.

P304

e0154679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0154679

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27159453

http://www.w3.org/2001/XMLSchema#string

P932

4861261

http://www.w3.org/2001/XMLSchema#string

Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors

about

P2860

P2860

Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932